Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$16.75 - $48.98 $5,159 - $15,085
308 Added 0.7%
44,238 $910,000
Q2 2023

Aug 14, 2023

BUY
$40.65 - $59.54 $186,380 - $272,990
4,585 Added 11.65%
43,930 $2.07 Million
Q1 2023

May 10, 2023

SELL
$37.27 - $46.57 $36,710 - $45,871
-985 Reduced 2.44%
39,345 $1.65 Million
Q4 2022

Feb 14, 2023

BUY
$32.2 - $43.61 $253,864 - $343,821
7,884 Added 24.3%
40,330 $1.54 Million
Q3 2022

Nov 14, 2022

SELL
$32.28 - $43.27 $83,669 - $112,155
-2,592 Reduced 7.4%
32,446 $1.27 Million
Q2 2022

Aug 11, 2022

SELL
$27.52 - $37.99 $705,998 - $974,595
-25,654 Reduced 42.27%
35,038 $1.13 Million
Q1 2022

May 16, 2022

SELL
$30.71 - $45.71 $229,772 - $342,002
-7,482 Reduced 10.97%
60,692 $2.01 Million
Q4 2021

Feb 09, 2022

SELL
$37.06 - $47.11 $144,682 - $183,917
-3,904 Reduced 5.42%
68,174 $2.9 Million
Q3 2021

Nov 15, 2021

SELL
$40.26 - $57.37 $365,399 - $520,690
-9,076 Reduced 11.18%
72,078 $3.19 Million
Q2 2021

Aug 11, 2021

BUY
$54.88 - $79.29 $4.21 Million - $6.08 Million
76,719 Added 1729.85%
81,154 $4.61 Million
Q1 2021

May 07, 2021

BUY
$70.65 - $96.76 $313,332 - $429,130
4,435 New
4,435 $332,000
Q4 2017

Feb 05, 2018

SELL
$60.72 - $167.34 $2.24 Million - $6.17 Million
-36,874 Closed
0 $0
Q3 2017

Nov 03, 2017

BUY
$61.4 - $88.52 $2.26 Million - $3.26 Million
36,874
36,874 $2.3 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.